Certified by Founder Lodge
Sofinnova Investments
United States - Menlo Park, CA
INVESTOR
1 Disclosed Funding Rounds $53,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical
| Company | Date | Round | Raised |
|---|---|---|---|
 Antiva Biosciences, Inc. |
April, 27 ,2023 | Series E | $53,000,000 |
 Quanta Therapeutics |
May, 23 ,2023 | Series D | $50,000,000 |
 Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Scorability | $11,000,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
